Clinical Trial Update: A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) [Phase 2]

View source ↗

Summary

A long-term safety trial evaluating LUM-201 in children with idiopathic growth hormone deficiency who previously completed a LUM-201 trial (OraGrowtH211).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• LUM-201

Snippet

Sponsor: Lumos Pharma | Conditions: Growth Hormone Deficiency | Phase 2 | Status: ENROLLING_BY_INVITATION